EUVIMEDEUVIMED entdecken
Crossref

Molecular Hydrogen Therapy: Mechanistic Foundations, Engineering of Delivery, and Clinical Translation

Qin Zhang, Shaowu Cheng, Mo Yang

Advanced Clinical Engineering · 2026

DOI: 10.2738/ace.2026.0011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Clinical Engineering, 2026. Verfasst von Qin Zhang und 2 weiteren Autor:innen. Die Arbeit nennt 140 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular hydrogen (H 2 ) has emerged as a potential therapeutic agent with antioxidant, anti-inflammatory, cytoprotective, metabolic, and immunomodulatory effects. Its rapid diffusion across biological membranes facilitates tissue penetration, whereas low aqueous solubility, rapid elimination, and limited retention restrict conventional delivery. This review integrates the mechanisms, delivery technologies, therapeutic applications, safety, and translational barriers of hydrogen therapy, with particular emphasis on the therapeutic advantages and added risks of materials-enabled local and sustained H 2 generation across disease settings. Mechanistically, H 2 attenuates highly reactive oxygen and nitrogen species and regulates nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent antioxidant defenses, mitochondrial homeostasis, nuclear factor kappa B/NLR family pyrin domain-containing 3 (NF-κB/NLRP3)-mediated inflammation, programmed cell death, and host–microbial interactions. To overcome the limitations of inhalation and hydrogen-rich fluids, hydrogen-carrying nanosystems, in situ hydrogen-generating biomaterials, stimulus-responsive nanoplatforms, and biological production systems have been developed to improve localization and prolong H 2 availability. Experimental studies demonstrate therapeutic potential of H 2 in acute organ injury, cardiometabolic, neurological, respiratory, oncological, gastrointestinal, renal, and tissue-repair applications, but clinical evidence remains exploratory and most biomaterial-based systems remain limited to cellular and small-animal studies. The future development of hydrogen therapy should prioritize disease-specific indications and confirm H 2 -dependent efficacy, while material-based nanosystems should demonstrate controllable H 2 generation, biodegradability, manufacturing reproducibility, and long-term safety in large-animal studies and well-controlled clinical trials.

Zitieren

APA

Zhang, Q., Cheng, S., & Yang, M. (2026). Molecular Hydrogen Therapy: Mechanistic Foundations, Engineering of Delivery, and Clinical Translation. Advanced Clinical Engineering. https://doi.org/10.2738/ace.2026.0011

Vancouver

Zhang Q, Cheng S, Yang M. Molecular Hydrogen Therapy: Mechanistic Foundations, Engineering of Delivery, and Clinical Translation. Advanced Clinical Engineering. 2026. doi:10.2738/ace.2026.0011

BibTeX
@article{Zhang2026,
  author = {Zhang, Qin and Cheng, Shaowu and Yang, Mo},
  title = {Molecular Hydrogen Therapy: Mechanistic Foundations, Engineering of Delivery, and Clinical Translation},
  journal = {Advanced Clinical Engineering},
  year = {2026},
  doi = {10.2738/ace.2026.0011}
}
Kostenlos starten →